Recruiting Colorectal Cancer Studies in Houston
The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
To learn if cemiplimab can help to control dMMR colon cancer....
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations....
About Colorectal Cancer Clinical Trials in Houston
Colorectal cancer starts in the colon or rectum and is the third most common cancer diagnosed in both men and women. Early detection through screening significantly improves outcomes. Treatments include surgery, chemotherapy, radiation, and targeted therapies.
There are currently 2 colorectal cancer clinical trials recruiting participants in Houston, TEXAS. These studies are seeking a combined 81 participants. Research is being sponsored by M.D. Anderson Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Colorectal Cancer Clinical Trials in Houston — FAQ
Are there colorectal cancer clinical trials in Houston?
Yes, there are 2 colorectal cancer clinical trials currently recruiting in Houston, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Houston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.
Are clinical trials in Houston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.
What colorectal cancer treatments are being tested?
The 2 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for colorectal cancer.
Data updated March 2, 2026 from ClinicalTrials.gov